Targeted cancer therapy: the next generation of cancer treatment
TA Baudino - Current drug discovery technologies, 2015 - ingentaconnect.com
Cancer is one of the leading causes of death in the United States along with heart disease.
The hallmark of cancer treatment has been conventional chemotherapy. Chemotherapeutic …
The hallmark of cancer treatment has been conventional chemotherapy. Chemotherapeutic …
[HTML][HTML] Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases
Angiogenesis is a critical step in the progression of almost all human malignancies and
some other life-threatening diseases. Anti-angiogenic therapy is a novel and effective …
some other life-threatening diseases. Anti-angiogenic therapy is a novel and effective …
[HTML][HTML] RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer
Z Yang, T Wang, D Wu, Z Min, J Tan, B Yu - Journal of Experimental & …, 2020 - Springer
Abstract Background N6-Methyladenosine (m6A) modification has been implicated in
multiple processes for colon cancer development. IGF2BP3 was a newly reported m6A …
multiple processes for colon cancer development. IGF2BP3 was a newly reported m6A …
Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy
The immature and dysfunctional vascular network within solid tumors poses a substantial
obstacle to immunotherapy because it creates a hypoxic tumor microenvironment that …
obstacle to immunotherapy because it creates a hypoxic tumor microenvironment that …
Colorectal cancer chemotherapy: the evolution of treatment and new approaches
RM McQuade, V Stojanovska… - Current medicinal …, 2017 - ingentaconnect.com
Colorectal cancer (CRC) is one the greatest contributors to cancer related mortality.
Although 5 year survival rate for patients at the early stage of CRC (stages I and II) is above …
Although 5 year survival rate for patients at the early stage of CRC (stages I and II) is above …
Regorafenib (BAY 73‐4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
SM Wilhelm, J Dumas, L Adnane… - … journal of cancer, 2011 - Wiley Online Library
Angiogenesis, a critical driver of tumor development, is controlled by interconnected
signaling pathways. Vascular endothelial growth factor receptor (VEGFR) 2 and tyrosine …
signaling pathways. Vascular endothelial growth factor receptor (VEGFR) 2 and tyrosine …
Angiogenesis: an organizing principle for drug discovery?
J Folkman - Nature reviews Drug discovery, 2007 - nature.com
Angiogenesis—the process of new blood-vessel growth—has an essential role in
development, reproduction and repair. However, pathological angiogenesis occurs not only …
development, reproduction and repair. However, pathological angiogenesis occurs not only …
[HTML][HTML] From conventional to precision therapy in canine mammary cancer: a comprehensive review
G Valdivia, Á Alonso-Diez, D Pérez-Alenza… - Frontiers in veterinary …, 2021 - frontiersin.org
Canine mammary tumors (CMTs) are the most common neoplasm in intact female dogs.
Canine mammary cancer (CMC) represents 50% of CMTs, and besides surgery, which is the …
Canine mammary cancer (CMC) represents 50% of CMTs, and besides surgery, which is the …
Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy
Protein kinases have grown over the past few years as a crucial target for different cancer
types. With the multifactorial nature of cancer, and the fast development of drug resistance …
types. With the multifactorial nature of cancer, and the fast development of drug resistance …
Vascular endothelial growth factor (VEGF) signaling in tumor progression
R Roskoski Jr - Critical reviews in oncology/hematology, 2007 - Elsevier
Vascular endothelial cells are ordinarily quiescent in adult humans and divide less than
once per decade. When tumors reach a size of about 0.2–2.0 mm in diameter, they become …
once per decade. When tumors reach a size of about 0.2–2.0 mm in diameter, they become …